Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Halstenson

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1990
Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietinP A Abraham, J A Opsahl, P R Keshaviah, et al.
Biopharmaceutics & Drug Disposition|November 1, 1992
Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1J A Smithers, G A Thompson, M T Kenny, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1990
Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietinP A Abraham, J A Opsahl, P R Keshaviah, et al.
Biopharmaceutics & Drug Disposition|November 1, 1992
Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1J A Smithers, G A Thompson, M T Kenny, et al.
Pageof 9